We are live on ! Find out more
KURA icon

Kura Oncology

148 hedge funds and large institutions have $1.26B invested in Kura Oncology in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 44 increasing their positions, 52 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more call options, than puts

Call options by funds: $3.49M | Put options by funds: $1.14M

120% more funds holding in top 10

Funds holding in top 10: 511 (+6)

13% more capital invested

Capital invested by funds: $1.11B → $1.26B (+$144M)

2.91% more ownership

Funds ownership: 100.12%103.03% (+2.9%)

10% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 21

3% less funds holding

Funds holding: 152148 (-4)

15% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 52

Holders
148
Holders Change
-4
Holders Change %
-2.63%
% of All Funds
2.49%
Holding in Top 10
11
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+120%
% of All Funds
0.19%
New
19
Increased
44
Reduced
52
Closed
21
Calls
$3.49M
Puts
$1.14M
Net Calls
+$2.35M
Net Calls Change
-$3.57M
Name Holding Trade Value Shares
Change
Change in
Stake
DCM
101
Dupont Capital Management
Delaware
$289K
ASRS
102
Arizona State Retirement System
Arizona
$281K +$561 +39 +0.3%
SMH
103
Sanders Morris Harris
Texas
$276K
BNP Paribas Financial Markets
104
BNP Paribas Financial Markets
France
$259K -$208K -14,461 -51%
AS
105
Altshuler Shaham
Israel
$255K
CSS
106
Cubist Systematic Strategies
Connecticut
$230K -$70.2K -4,879 -28%
BC
107
BIT Capital
Germany
$229K
ProShare Advisors
108
ProShare Advisors
Maryland
$226K -$93.4K -6,491 -35%
PAM
109
Panagora Asset Management
Massachusetts
$212K +$167K +11,590 New
CM
110
Caption Management
Oklahoma
$211K -$769K -53,482 -82%
Janus Henderson Group
111
Janus Henderson Group
United Kingdom
$210K -$216 -15 -0.1%
DU
112
Delphia (USA)
Ontario, Canada
$210K +$164K +11,430 New
Public Employees Retirement Association of Colorado
113
Public Employees Retirement Association of Colorado
Colorado
$207K
EAM
114
Erste Asset Management
Austria
$200K
Principal Financial Group
115
Principal Financial Group
Iowa
$198K +$155K +10,788 New
EFM
116
E Fund Management
China
$194K +$152K +10,573 New
NAM
117
NorthCrest Asset Manangement
Minnesota
$192K
CC
118
Corton Capital
Ontario, Canada
$191K -$24.2K -1,685 -14%
AB
119
Amalgamated Bank
New York
$147K +$5.26K +366 +5%
TRCT
120
Tower Research Capital (TRC)
New York
$142K +$86.2K +5,990 +341%
VEA
121
Virtus ETF Advisers
New York
$139K -$72.1K -5,009 -40%
Zurich Cantonal Bank
122
Zurich Cantonal Bank
Switzerland
$127K
DA
123
Denali Advisors
California
$119K +$38.8K +2,700 +71%
AIP
124
Ameritas Investment Partners
Nebraska
$87K -$7K -487 -9%
MLICM
125
Metropolitan Life Insurance Company (MetLife)
New York
$76.1K

KURA Hedge Fund Activity: Q2 2022 in Review

148 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q2 2022, worth a combined $1.26B — up 13% from $1.11B a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of KURA and 19 opened new positions — a net loss of 2 holders — while 52 trimmed existing stakes and 44 added.

The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $20.6M. The largest seller was Deerfield Management, cutting an estimated $25.7M.

  • 148 institutional investors held Kura Oncology (KURA) as of Q2 2022, down from 152 in Q1 2022.
  • Funds reported $1.26B of Kura Oncology stock for Q2 2022, up 13% quarter-over-quarter.
  • 19 funds opened new Kura Oncology positions in Q2 2022 and 21 closed out, a net change of -2 holders.
  • The largest Kura Oncology buyer in Q2 2022 was Balyasny Asset Management, an estimated $20.6M added.
  • The largest Kura Oncology seller in Q2 2022 was Deerfield Management, an estimated $25.7M sold.

Based on aggregated 13F filings for Q2 2022.